NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), Olo, Inc. (NYSE: OLO), Cognyte Software Ltd. (NASDAQ: CGNT) and World Wrestling Entertainment, Inc. (NYSE: WWE). Our investigations address whether these companies have violated federal securities laws and/or engaged in other illegal business practices. For more information on each case, see the link provided.

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

On August 30, 2022, after the market close, EyePoint announced that it had received a subpoena from the United States Attorney for the District of Massachusetts. The subpoena requested documents covering the company’s sales practices for its post-surgical inflammation treatment DEXYCU.

As a result of this news, EyePoint stock fell $0.21 per share, or 2%, to close at $10.00 per share on August 31, 2022.

For more information on the EyePoint exam, visit: https://bespc.com/cases/EYPT

Olo, Inc. (NYSE: OLO)

On February 12, 2020, Olo issued a press release in which it “announced its partnership with Subway(R) restaurants to integrate digital ordering directly into the restaurant’s point of sale for most of the chain’s locations.” Olo also stated that “[t]The partnership will enable Subway’s network of more than 20,000 US restaurants to more seamlessly fulfill digital orders from third-party marketplaces.”

Then, on August 11, 2022, Olo issued a press release announcing its second quarter 2022 financial results. On a conference call with investors and analysts later that day to discuss these results, Olo announced a change in its relationship with Subway that occurred in the second quarter. Specifically, Olo’s founder and chief executive officer announced that the company is in the process of losing its business from Subway, that it is about…